Skip to main content

Some 14% of Muscovites develop antibodies to COVID-19 – mayor

NewsColony
Some 14% of Muscovites develop antibodies to COVID-19 – mayor

MOSCOW, May 29. /TASS/. Screening tests in Moscow showed that 14% of those tested have developed antibodies to the coronavirus, Moscow Mayor Sergey Sobyanin told Rossiya-24 TV channel.

“Screening tests that we are conducting in the capital today revealed that 14% have markers to the coronavirus. This is a large percent. Some of them are at the stage of developing immunity,” Sobyanin said.

To date, a total of 379,051 coronavirus cases have been confirmed in Russia, with 150,993 patients having recovered from the disease. Russia’s latest data indicates 4,142 fatalities nationwide. Earlier, the Russian government set up an Internet hotline to keep the public updated on the coronavirus situation.

Moscow has been the most affected by the coronavirus, but lately the situation has started improving. In the past day, the number of recoveries again surpassed the tally of new cases, reaching 3,793 versus 2,054. A total of 173,497 people in the city have contracted the virus, some 71,251 have recovered and 2,254 have died. The Russian capital has launched a large-scale voluntary campaign to conduct tests for antibodies to COVID-19.

Source: TASS

The post Some 14% of Muscovites develop antibodies to COVID-19 – mayor appeared first on NewsColony.
NewsColony



source https://newscolony.com/some-14-of-muscovites-develop-antibodies-to-covid-19-mayor/

Comments

Post a Comment

Popular posts from this blog

What you should do if you have coronavirus

NewsColony What you should do if you have coronavirus Click to expand Replay Video UP NEXT Watch a COVID-19 Lab Test Watch a COVID-19 Lab Test Redding Record Searchlight Redding’s first cannabis store, Synergy, opens for business Redding’s first cannabis store, Synergy, opens for business Redding Record Searchlight Five tips to be a rock painter Five tips to be a rock painter Redding Record Searchlight SETTINGS OFF HD HQ SD LO Skip Ad UP NEXT You wake up with a dry cough or headache. It could be the common cold or allergies, or it could be the coronavirus.  So, what should you do next?  The Centers for Disease Control and Prevention and other public health experts recommend taking the following steps if you’re feeling sick and think you may have COVID-19.  Start the day smarter. Get all the news you need in your inbox each morning. Do an inventory of symptoms:  Dry...
Post a Comment
Read more

Coronavirus Live Updates: Online Retailers Plan Campaign to Rescue Postal Service

NewsColony Coronavirus Live Updates: Online Retailers Plan Campaign to Rescue Postal Service Here’s what you need to know: Image A United States Postal Service employee making deliveries in the Bronx last month. Credit… Desiree Rios for The New York Times Online retailers, including Amazon, want Congress to save the Postal Service. A coalition of online retailers backed by Amazon plans to start on Wednesday a seven-figure advertising blitz opposing President Trump’s demand that the beleaguered United States Postal Service ratchet up its package delivery rates to avoid bankruptcy during the coronavirus crisis, its top lobbyist said. The ads will begin running nationally Wednesday night on “Hannity,” one of Mr. Trump’s favorite programs on Fox News, and on Rush Limbaugh’s radio show on Thursday. They do not mention the president but label his proposal to raise delivery prices “a massive package tax” on small businesses and Americans who rely on the mail for pre...
Post a Comment
Read more

China’s military is world’s first to use experimental virus vaccine

NewsColony China’s military is world’s first to use experimental virus vaccine © AFP An experimental coronavirus vaccine has been approved for use by the Chinese military – a first for the armed forces of any country. Photo: AFP China has approved military use of an experimental coronavirus vaccine developed by the People’s Liberation Army and a Chinese pharmaceutical company, in a first for the armed forces of any country. The vaccine, identified as Ad5-nCoV, was jointly developed by a team at the Academy of Military Medical Sciences, led by Major General Chen Wei, and Tianjin-based company CanSino Biologics . It is the first time that a vaccine candidate for Covid-19, the disease caused by the coronavirus, has been authorised for use for the military of any nation. CanSino said on Monday that the candidate had been through two phases of clinical trials, which indicated it was safe and there was “relatively high” immune response to the antigen. The candidate is yet to start ...
Post a Comment
Read more